The Global Hemostasis and Tissue Sealing Agents Market is driven by rising surgical procedures
The global hemostasis and tissue sealing agents market comprises medical devices and drugs that promote hemostasis or stop bleeding during surgical procedures. Hemostatic agents help control bleeding by accelerating the blood clotting process, while tissue sealing products create mechanical or biological seals to close incisions and wounds. Some common hemostasis products include bone wax, surgical sealants, absorbable and non-absorbable hemostats. On the other hand, advanced tissue sealing devices utilize bipolar or ultrasonic technology to denature collagen and elastin fibers within tissue, sealing off blood vessels and creating welds.
The rising volume of surgical procedures performed globally is a major factor driving Hemostasis And Tissue Sealing Agents Market Growth. According to statistical estimates, over 312 million surgical procedures were performed worldwide in 2020, a significant increase from previous years. As the geriatric population prone to chronic diseases grows rapidly, the demand for various medical and cosmetic surgeries is projected to remain high. This will correspondingly bolster the consumption of hemostatic drugs and sealing devices that help expedite postoperative recovery and prevent excessive bleeding complications.
The Global Hemostasis And Tissue Sealing Agents Market is estimated to be valued at US$ 8.9 billion in 2025 and is expected to exhibit a CAGR of 5.6% over the forecast period 2025-2032.
Key Takeaways
Key players operating in the Hemostasis and Tissue Sealing Agents are Ethicon (Johnson and Johnson), Baxter International Inc., Integra LifeSciences Corporation, B Braun Melsungen AG, CryoLife Inc.
The growing demand in market and third paragraph is talking about global expansion of market. With rising surgical volumes across both developed and developing nations, the consumption of hemostasis agents and tissue sealants is increasing at a significant pace. Various clinical studies have demonstrated the efficacy of advanced hemostats and sealants in reducing operative bleedings and complications compared to conventional procedures. This is persuading more healthcare facilities to adopt tissue sealing technology.
Get More Insights on Hemostasis And Tissue Sealing Agents Market
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian